Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2022-09-09 19:17:30 UTC
Update Date2022-09-22 18:35:02 UTC
HMDB IDHMDB0341139
Secondary Accession NumbersNone
Metabolite Identification
Common NameBufexamac
DescriptionBufexamac, also known as bufexamic acid or anderm, belongs to the class of organic compounds known as phenylacetamides. These are amide derivatives of phenylacetic acids. Bufexamac is an extremely weak basic (essentially neutral) compound (based on its pKa).
Structure
Thumb
Synonyms
ValueSource
2-(p-Butoxyphenyl)-acetohydroxamic acidChEBI
4-Butoxy-N-hydroxybenzeneacetamideChEBI
4-Butoxyphenylacetohydroxamic acidChEBI
Acide p-butoxyphenylacethydroxamiqueChEBI
BufexamacoChEBI
BufexamacumChEBI
Bufexamic acidChEBI
p-Butoxyphenylacetohydroxamic acidChEBI
AndermKegg
2-(p-Butoxyphenyl)-acetohydroxamateGenerator
4-ButoxyphenylacetohydroxamateGenerator
BufexamateGenerator
p-ButoxyphenylacetohydroxamateGenerator
AllergipuranMeSH
Bioglan brand OF bufexamacMeSH
Bufexamac scheurich brandMeSH
Sanofi synthelabo brand OF bufexamacMeSH
Whitehall brand OF bufexamacMeSH
WindolMeSH
AHP brand OF bufexamacMeSH
Bufexamac-ratiopharmMeSH
DroxarylMeSH
MalipuranMeSH
Scheurich brand OF bufexamacMeSH
P Butoxyphenylacethydroxamic acidMeSH
Merck dura brand OF bufexamacMeSH
Bufexamac dermapharm brandMeSH
Bufexamac galenpharma brandMeSH
Bufexamac ratiopharmMeSH
Pfizer brand OF bufexamacMeSH
BufexamacMeSH
BufalMeSH
BufedermMeSH
Bufexamac ratiopharm brandMeSH
Dermapharm brand OF bufexamacMeSH
JomaxMeSH
ParadermMeSH
P-Butoxyphenylacethydroxamic acidMeSH
Bufexamac ahp brandMeSH
Bufexamac pfizer brandMeSH
Pierre fabre brand OF bufexamacMeSH
Bufexamac bioglan brandMeSH
Bufexamac whitehall brandMeSH
BufexamacratiopharmMeSH
GALENpharma brand OF bufexamacMeSH
ParfenacMeSH
DuradermalMeSH
Ratiopharm brand OF bufexamacMeSH
Chemical FormulaC12H17NO3
Average Molecular Weight223.272
Monoisotopic Molecular Weight223.120843411
IUPAC NameN-hydroxy2-(4-butoxyphenyl)ethanimidic acid
Traditional Namejomax
CAS Registry NumberNot Available
SMILES
CCCCOC1=CC=C(CC(O)=NO)C=C1
InChI Identifier
InChI=1S/C12H17NO3/c1-2-3-8-16-11-6-4-10(5-7-11)9-12(14)13-15/h4-7,15H,2-3,8-9H2,1H3,(H,13,14)
InChI KeyMXJWRABVEGLYDG-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as phenylacetamides. These are amide derivatives of phenylacetic acids.
KingdomOrganic compounds
Super ClassBenzenoids
ClassBenzene and substituted derivatives
Sub ClassPhenylacetamides
Direct ParentPhenylacetamides
Alternative Parents
Substituents
  • Phenylacetamide
  • Phenoxy compound
  • Phenol ether
  • Alkyl aryl ether
  • Hydroxamic acid
  • Carboxylic acid derivative
  • Ether
  • Organopnictogen compound
  • Organooxygen compound
  • Organonitrogen compound
  • Organic oxygen compound
  • Organic nitrogen compound
  • Carbonyl group
  • Organic oxide
  • Hydrocarbon derivative
  • Aromatic homomonocyclic compound
Molecular FrameworkAromatic homomonocyclic compounds
External Descriptors
Ontology
Not AvailableNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP2.5ALOGPS
logP2.79ChemAxon
logS-3.1ALOGPS
pKa (Strongest Acidic)4.54ChemAxon
pKa (Strongest Basic)0.39ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area62.05 ŲChemAxon
Rotatable Bond Count6ChemAxon
Refractivity61.81 m³·mol⁻¹ChemAxon
Polarizability24.35 ųChemAxon
Number of Rings1ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Kovats Retention Indices

Not Available
Spectra

MS/MS Spectra

Spectrum TypeDescriptionSplash KeyDeposition DateSourceView
Experimental LC-MS/MSLC-MS/MS Spectrum - Bufexamac LC-ESI-QFT , negative-QTOFsplash10-00di-1090000000-f24ae0d85b1376dd66952017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Bufexamac LC-ESI-QFT , negative-QTOFsplash10-00di-5390000000-1064111002b4036cfbbb2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Bufexamac LC-ESI-QFT , negative-QTOFsplash10-0aor-7900000000-789660a43653a49880b82017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Bufexamac LC-ESI-QFT , negative-QTOFsplash10-066r-5900000000-91ae318ee7bf4a0c8ebb2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Bufexamac LC-ESI-QFT , negative-QTOFsplash10-014i-4900000000-15c66804db050221c3312017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Bufexamac LC-ESI-QFT , negative-QTOFsplash10-014i-3900000000-a41498b64629a3eda39c2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Bufexamac LC-ESI-qTof , Positive-QTOFsplash10-08mi-0920000000-e2854ce6292c5d0a1c8c2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Bufexamac LC-ESI-qTof , Positive-QTOFsplash10-0a4i-4910100000-7ff98d442e9aa0a2f64d2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Bufexamac LC-ESI-QFT , positive-QTOFsplash10-03di-0920000000-9e2d982e08339f818cf62017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Bufexamac LC-ESI-QFT , positive-QTOFsplash10-0bt9-0900000000-435c1f72113403e534fa2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Bufexamac LC-ESI-QFT , positive-QTOFsplash10-0a4i-0900000000-9de68224c670d85b56212017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Bufexamac LC-ESI-QFT , positive-QTOFsplash10-0a4i-0900000000-496edd1f1dfb18e3bc932017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Bufexamac LC-ESI-QFT , positive-QTOFsplash10-0a4i-1900000000-3e269c82012ba53557c22017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Bufexamac LC-ESI-QFT , positive-QTOFsplash10-0a4i-2900000000-80c7b8b429b26dfbbfc62017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Bufexamac , positive-QTOFsplash10-08mi-0920000000-e2854ce6292c5d0a1c8c2017-09-14HMDB team, MONAView Spectrum
Experimental LC-MS/MSLC-MS/MS Spectrum - Bufexamac , positive-QTOFsplash10-0a4i-4910100000-7ff98d442e9aa0a2f64d2017-09-14HMDB team, MONAView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Bufexamac 10V, Negative-QTOFsplash10-00di-2790000000-a888ce6056e5f170d8f72016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Bufexamac 20V, Negative-QTOFsplash10-0cdm-7920000000-844caa547238084d9a5d2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Bufexamac 40V, Negative-QTOFsplash10-052b-7900000000-dd69ba5273b008ba5b9f2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Bufexamac 10V, Positive-QTOFsplash10-00di-3790000000-4039782277746e9f762f2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Bufexamac 20V, Positive-QTOFsplash10-0bt9-3910000000-1551e839edb87240079d2016-08-03Wishart LabView Spectrum
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - Bufexamac 40V, Positive-QTOFsplash10-0a4i-9300000000-0b2e57d6765bd1d7de8e2016-08-03Wishart LabView Spectrum
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
  • Urine
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodExpected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
UrineDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDDB13346
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider IDNot Available
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkBufexamac
METLIN IDNot Available
PubChem CompoundNot Available
PDB IDNot Available
ChEBI ID31317
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Neto FC, Raftery D: Expanding Urinary Metabolite Annotation through Integrated Mass Spectral Similarity Networking. Anal Chem. 2021 Sep 7;93(35):12001-12010. doi: 10.1021/acs.analchem.1c02041. Epub 2021 Aug 26. [PubMed:34436864 ]